www.ahrq.gov/

Visit: National Guideline Clearinghouse | Health Care Innovations Exchange | AHRQ Home Sign In

Help| RSS|

Subscribe to weekly e-mail | Site map| Site tutorial Contact us| For web developers

Search Tips Advanced Search About Search

Measures by Topic

Disease/Condition > Diseases (1475) >

Neoplasms (183)

Narrow:

Neoplasms by Histologic Type (38)
Neoplasms by Site (117)
Neoplasms, Hormone-Dependent (1)

View all...

Search Within Search within: Go

Sort results by: Relevance Publication date

Filter results by:

1-20 of 183 Next >

Cancer - anorexia and weight loss: percentage of patients treated with an appetite stimulant for anorexia who had an assessment before or on the next visit to the same outpatient site of whether or not there was an improvement in anorexia. 2010 Apr. NQMC:006145
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

Cancer - anorexia and weight loss: percentage of patients treated with enteral or parenteral nutrition who had an assessment prior to starting nutrition that there was difficulty maintaining nutrition due to significant gastrointestinal issues and that expected life expectancy was at least one month. 2010 Apr. NQMC:006146
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

Cancer - anorexia and weight loss: percentage of patients who presented for an initial visit for cancer affecting the oropharynx or gastrointestinal tract or advanced cancer at a cancer-related outpatient site for whom there was an assessment for the presence or absence of anorexia or dysphagia. 2010 Apr. NQMC:006144
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

Cancer - delirium: percentage of hospitalized patients with cancer over the age of 65 or with advanced cancer with delirium for whom there was an assessment for the presence or absence of at least one of the following potential causes and their association with delirium: medication effects, central nervous system disease, infection, or metabolic processes. 2010 Apr. NQMC:006155
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

Cancer - depression and psychosocial distress: percentage of patients diagnosed with depression for whom a treatment plan for depression was documented. 2010 Apr. NQMC:006131
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

Cancer - depression and psychosocial distress: percentage of patients treated for depression for whom a response to therapy was documented within 6 weeks. 2010 Apr. NQMC:006132
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

Cancer - diarrhea: percentage of patients undergoing chemotherapy who have diarrhea for whom all of the following were assessed: history of onset and duration, number of stools and stool composition, and at least one of the associated symptoms (fever, dizziness, abdominal pain/cramping, nausea/vomiting, decreased performance status, sepsis, fever, bleeding, or dehydration), in order to classify the diarrhea as complicated or uncomplicated. 2010 Apr. NQMC:006153
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

Cancer - diarrhea: percentage of patients undergoing chemotherapy with a high-risk (greater than 10%) of chemotherapy-induced diarrhea for whom an antidiarrheal agent was prescribed on or before treatment was initiated. 2010 Apr. NQMC:006154
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

Cancer - dyspnea: percentage of inpatients with primary lung cancer or advanced cancer with dyspnea on admission who were offered symptomatic management or treatment directed at an underlying cause within 24 hours. 2010 Apr. NQMC:006149
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

10.

Cancer - dyspnea: percentage of outpatients with primary lung cancer or advanced cancer who reported new or worsening dyspnea who were offered symptomatic management or treatment directed at an underlying cause within one month. 2010 Apr. NQMC:006148
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

11.

Cancer - dyspnea: percentage of patients in the hospital treated for dyspnea who had an assessment within 24 hours that the treatment was effective in relieving dyspnea or that a change in treatment for dyspnea was made. 2010 Apr. NQMC:006150
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

12.

Cancer - dyspnea: percentage of patients who reported new or worsening dyspnea for whom there was documentation of cause or of investigation of at least one of the following: hypoxia, anemia, bronchospasm or chronic obstructive pulmonary disease, pleural effusion, tumor obstruction of bronchi or the trachea, pneumonia, or pulmonary embolism. 2010 Apr. NQMC:006147
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

13.

Cancer - dyspnea: percentage of patients with a malignant pleural effusion who underwent thoracentesis for whom there was a repeat assessment of dyspnea within one week. 2010 Apr. NQMC:006152
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

14.

Cancer - dyspnea: percentage of patients with dyspnea and a malignant pleural effusion who were offered thoracentesis within one month of the initial diagnosis of the effusion, or other treatment (e.g., diuresis) that resulted in a reduction in the effusion or symptomatic dyspnea. 2010 Apr. NQMC:006151
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

15.

Cancer - fatigue/anemia: percentage of known cancer patients who are newly diagnosed with cancer who had an assessment of the presence or absence of fatigue. 2010 Apr. NQMC:006141
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

16.

Cancer - fatigue/anemia: percentage of patients found to have anemia with a hemoglobin less than 10 g/dl for whom the presence and severity of anemia-related symptoms (e.g., fatigue, dyspnea, and lightheadedness) were evaluated. 2010 Apr. NQMC:006142
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

17.

Cancer - fatigue/anemia: percentage of patients found to have severe, symptomatic anemia (hemoglobin less than 8 g/dl) for whom transfusion with packed red cells was offered within 24 hours. 2010 Apr. NQMC:006143
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

18.

Cancer - fatigue/anemia: percentage of patients seen for an initial visit or any visit while undergoing chemotherapy at a cancer-related outpatient site for whom there was an assessment of the presence or absence of fatigue. 2010 Apr. NQMC:006140
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

19.

Cancer - information and care planning: percentage of patients who underwent chemotherapy and, prior to chemotherapy, were informed about the risks and benefits of treatment, including likely symptoms and side effects, and whether the treatment intent is curative or palliative. 2010 Apr. NQMC:006161
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

20.

Cancer - information and care planning: percentage of patients with advanced cancer who are admitted to the ICU and survive 48 hours for whom the patient's preferences for care or an attempt to identify them was documented in the medical record within 48 hours of ICU admission. 2010 Apr. NQMC:006159
RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)

Compare Selected

1-20 of 183 Next >

Agency for Healthcare Research and Quality 540 Gaither Road Rockville, MD 20850 Telephone: (301) 427-1364